Motus GI Holdings (Motus GI Holdings) 5-Year EBITDA Growth Rate : 44.60% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings 5-Year EBITDA Growth Rate?

Motus GI Holdings's EBITDA per Share for the three months ended in Dec. 2023 was $-1.68.

During the past 3 years, the average EBITDA Per Share Growth Rate was 56.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 44.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Motus GI Holdings was 56.40% per year. The lowest was -12.10% per year. And the median was 33.90% per year.

Competitive Comparison of Motus GI Holdings's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Motus GI Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's 5-Year EBITDA Growth Rate falls into.

Motus GI Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Motus GI Holdings (OTCPK:MOTS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Motus GI Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Motus GI Holdings (Motus GI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Executives

Orchestra Biomed Holdings, Inc.	10 percent owner	150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin	director	PO BOX 376, ANN ARBOR MI 48106
Elad Amor	officer: Chief Accounting Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram	officer: Chief Financial Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran	director, officer: Chief Executive Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor	officer: Chief Financial Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz	director, officer: President and COO	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp	other: * See Remarks	200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg	other: * See Remarks	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman	director, other: Chairman of the Board	15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy	director	850 PARK AVENUE, APT. 12B, NEW YORK NY 10075